Tidal Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.97M | Buy |
13,280
+2,756
| +26% | +$1.45M | 0.04% | 368 |
|
|
2025
Q1 | $6.67M | Buy |
10,524
+2,809
| +36% | +$1.78M | 0.05% | 333 |
|
|
2024
Q4 | $5.5M | Buy |
7,715
+1,365
| +21% | +$972K | 0.04% | 382 |
|
|
2024
Q3 | $6.68M | Buy |
6,350
+510
| +9% | +$536K | 0.07% | 259 |
|
|
2024
Q2 | $6.14M | Buy |
5,840
+885
| +18% | +$930K | 0.08% | 219 |
|
|
2024
Q1 | $4.77M | Buy |
4,955
+711
| +17% | +$685K | 0.08% | 237 |
|
|
2023
Q4 | $3.73M | Buy |
4,244
+122
| +3% | +$107K | 0.09% | 196 |
|
|
2023
Q3 | $3.39M | Sell |
4,122
-2,178
| -35% | -$1.79M | 0.1% | 199 |
|
|
2023
Q2 | $4.53M | Buy |
6,300
+799
| +15% | +$574K | 0.13% | 140 |
|
|
2023
Q1 | $4.52M | Sell |
5,501
-2,717
| -33% | -$2.23M | 0.15% | 135 |
|
|
2022
Q4 | $5.93M | Buy |
8,218
+2,047
| +33% | +$1.48M | 0.23% | 87 |
|
|
2022
Q3 | $4.25M | Sell |
6,171
-1,027
| -14% | -$707K | 0.18% | 109 |
|
|
2022
Q2 | $4.26M | Buy |
7,198
+1,336
| +23% | +$790K | 0.16% | 116 |
|
|
2022
Q1 | $4.09M | Sell |
5,862
-371
| -6% | -$259K | 0.12% | 133 |
|
|
2021
Q4 | $3.94M | Buy |
6,233
+2,454
| +65% | +$1.55M | 0.12% | 132 |
|
|
2021
Q3 | $2.29M | Buy |
3,779
+2,109
| +126% | +$1.28M | 0.09% | 164 |
|
|
2021
Q2 | $933K | Buy |
1,670
+701
| +72% | +$392K | 0.04% | 304 |
|
|
2021
Q1 | $458K | Buy |
969
+199
| +26% | +$94.1K | 0.02% | 317 |
|
|
2020
Q4 | $372K | Buy |
770
+140
| +22% | +$67.6K | 0.03% | 271 |
|
|
2020
Q3 | $353K | Buy |
630
+82
| +15% | +$45.9K | 0.05% | 180 |
|
|
2020
Q2 | $342K | Buy |
548
+34
| +7% | +$21.2K | 0.05% | 198 |
|
|
2020
Q1 | $251K | Buy |
+514
| New | +$251K | 0.07% | 184 |
|